You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

FENTANYL CITRATE PRESERVATIVE FREE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fentanyl Citrate Preservative Free, and when can generic versions of Fentanyl Citrate Preservative Free launch?

Fentanyl Citrate Preservative Free is a drug marketed by Dr Reddys, Fresenius Kabi Usa, and Hospira. and is included in three NDAs.

The generic ingredient in FENTANYL CITRATE PRESERVATIVE FREE is fentanyl citrate. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fentanyl Citrate Preservative Free

A generic version of FENTANYL CITRATE PRESERVATIVE FREE was approved as fentanyl citrate by HIKMA on July 11th, 1984.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FENTANYL CITRATE PRESERVATIVE FREE?
  • What are the global sales for FENTANYL CITRATE PRESERVATIVE FREE?
  • What is Average Wholesale Price for FENTANYL CITRATE PRESERVATIVE FREE?
Summary for FENTANYL CITRATE PRESERVATIVE FREE
Drug patent expirations by year for FENTANYL CITRATE PRESERVATIVE FREE
Pharmacology for FENTANYL CITRATE PRESERVATIVE FREE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for FENTANYL CITRATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys FENTANYL CITRATE PRESERVATIVE FREE fentanyl citrate INJECTABLE;INJECTION 074917-001 Feb 3, 1998 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Fresenius Kabi Usa FENTANYL CITRATE PRESERVATIVE FREE fentanyl citrate INJECTABLE;INJECTION 210762-001 May 3, 2019 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira FENTANYL CITRATE PRESERVATIVE FREE fentanyl citrate INJECTABLE;INJECTION 072786-001 Sep 24, 1991 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

FENTANYL CITRATE PRESERVATIVE FREE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Fentanyl Citrate Preservative Free

Introduction to Fentanyl Citrate

Fentanyl citrate is a potent synthetic opioid used for various medical purposes, including anesthesia, breakthrough cancer pain, and round-the-clock pain management. Its high potency and versatility have made it a significant player in the pharmaceutical market.

Medical Uses and Forms of Fentanyl Citrate

Fentanyl citrate is available in several formulations, each designed for specific routes of administration. These include orally disintegrating tablets (e.g., Fentora), transmucosal lozenges (e.g., Actiq), sublingual tablets, sublingual spray, nasal spray, and injectable solutions[1][4].

Market Demand and Patient Needs

The demand for fentanyl citrate is driven by the need for effective pain management, particularly in patients with chronic cancer pain. The drug's ability to provide rapid and potent analgesia makes it a preferred option for breakthrough pain in patients already on maintenance opioid therapy[1].

Regulatory Environment

Fentanyl citrate products are subject to stringent regulatory oversight due to their potential for abuse and overdose. Regulatory bodies such as the Therapeutic Goods Administration (TGA) in Australia and the FDA in the United States closely monitor the approval, manufacturing, and distribution of these products. For instance, the TGA approved Fentora, an orally disintegrating tablet formulation of fentanyl citrate, with specific guidelines for its use and monitoring[1].

Bioavailability and Pharmacokinetics

The bioavailability of fentanyl citrate varies by formulation. For example, buccal tablets have a bioavailability of 65%, while sublingual spray is 76% bioavailable. These pharmacokinetic properties influence the drug's efficacy and safety profile, which in turn affect market acceptance and patient compliance[4].

Manufacturing and Quality Control

The manufacturing process for fentanyl citrate involves strict adherence to Good Manufacturing Practice (GMP) standards. The quality of the active ingredient and finished products is crucial, with detailed specifications for release and expiry. The use of appropriate packaging, such as blister packs, is essential to protect the product from degradation[1].

Financial Aspects: Pricing and Revenue

The financial trajectory of fentanyl citrate is influenced by several factors, including production costs, regulatory approvals, and market demand. The drug is generally expensive due to its complex manufacturing process and the need for stringent quality control. For instance, Fentora tablets are available in various strengths, and their pricing reflects the potency and the specific formulation[1].

Illicit Market Impact

The illicit market for fentanyl also affects its financial dynamics. Fentanyl's high potency and low volume make it an attractive substance for illegal trade. On darknet markets, fentanyl can be purchased at significant prices, with 10 grams potentially generating millions of dollars in revenue. This illicit trade can impact the legitimate market by influencing public perception and regulatory scrutiny[3].

Market Trends and Competition

The market for fentanyl citrate is competitive, with multiple formulations and brands available. Companies like Orphan Australia Pty Ltd and others invest heavily in research and development to improve delivery methods and patient outcomes. The introduction of new formulations, such as Fentora, has expanded the market by offering rapid delivery and enhanced absorption compared to older products like Actiq[1].

Darknet Markets and Global Trade

The availability of fentanyl on darknet markets has global implications. These markets facilitate the trade of fentanyl and its analogues, contributing to the opioid epidemic. The ease of shipping small quantities of fentanyl due to its high potency makes it a lucrative but dangerous commodity[3].

Safety and Abuse Potential

Fentanyl citrate's high abuse potential is a significant concern. The drug's potency increases the risk of overdose, and its use must be closely monitored by healthcare professionals. Regulatory bodies and healthcare providers must balance the need for effective pain management with the risk of abuse and overdose[2][4].

Public Health Impact

The public health impact of fentanyl citrate is multifaceted. On one hand, it provides essential pain relief for patients with severe pain. On the other hand, its misuse contributes to the opioid epidemic, leading to significant public health challenges and economic burdens. Public health initiatives focus on safe prescribing practices, monitoring, and education to mitigate these risks[3].

Future Outlook

The future of fentanyl citrate in the market will be shaped by ongoing research, regulatory changes, and public health initiatives. Innovations in delivery methods and formulations are expected to continue, improving patient outcomes while minimizing risks. However, the illicit trade and abuse potential will remain critical issues that need to be addressed through comprehensive strategies.

Key Takeaways

  • Medical Uses: Fentanyl citrate is used for anesthesia, breakthrough cancer pain, and round-the-clock pain management.
  • Formulations: Available in various forms, including orally disintegrating tablets, transmucosal lozenges, sublingual tablets, sublingual spray, nasal spray, and injectable solutions.
  • Regulatory Oversight: Strict regulatory guidelines due to high abuse potential and overdose risk.
  • Bioavailability: Varies by formulation, influencing efficacy and safety.
  • Financial Aspects: High production costs and significant revenue potential, affected by illicit market activities.
  • Market Trends: Competitive market with ongoing innovation in delivery methods.
  • Public Health Impact: Essential for pain relief but contributes to the opioid epidemic.

FAQs

Q: What are the primary medical uses of fentanyl citrate?

A: Fentanyl citrate is primarily used for anesthesia, breakthrough cancer pain, and round-the-clock pain management.

Q: How does the bioavailability of fentanyl citrate vary by formulation?

A: Bioavailability varies significantly by formulation; for example, buccal tablets are 65% bioavailable, while sublingual spray is 76% bioavailable[4].

Q: What are the regulatory challenges associated with fentanyl citrate?

A: Regulatory bodies closely monitor the approval, manufacturing, and distribution of fentanyl citrate due to its high abuse potential and overdose risk[1].

Q: How does the illicit market impact the financial trajectory of fentanyl citrate?

A: The illicit market affects pricing and revenue by influencing public perception and regulatory scrutiny, and it also contributes to the opioid epidemic[3].

Q: What are the future outlook and potential innovations for fentanyl citrate?

A: Future innovations are expected in delivery methods and formulations, with a focus on improving patient outcomes while minimizing risks. Public health initiatives will continue to address the risks associated with fentanyl citrate.

Sources

  1. Australian Public Assessment Report for Fentanyl citrate (Fentora) - Therapeutic Goods Administration.
  2. Fentanyl - StatPearls - NCBI Bookshelf.
  3. Fentanyl availability on darknet markets - Australian Institute of Criminology.
  4. Fentanyl: Uses, Interactions, Mechanism of Action | DrugBank Online.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.